Financials

Discussions Technicals Seasonals

373110 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to XCELL THERAPEUTICS INC. operating, investing, and financing activities

373110 free cash flow for Q2 24 is -2.27 B KRW. For 2023, 373110 free cash flow was -7.01 B KRW and operating cash flow was -6.78 B KRW.

Q1 '23

Q2 '23

Q1 '24

Q2 '24

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: KRW

Q1 '23

Q2 '23

Q1 '24

Q2 '24

TTM

YoY growth

—

—

—

—

—

YoY growth

—

—

—

—

—

YoY growth

—

—

—

—

—

YoY growth

—

—

—

—

—